You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
百洋醫藥(301015.SZ):與上海誼眾簽署市場推廣服務協議

格隆匯2月13日丨百洋醫藥(301015.SZ)公佈,為充分發揮雙方優勢,實現優勢互補,提高效率並尋求共同發展,近日百洋醫藥與上海誼眾簽署了《市場推廣服務協議》,就上海誼眾委託百洋醫藥在合作範圍內進行協議產品的推廣服務事宜達成約定。本協議有效期間自合同簽訂之日起至2025年12月31日止。如在以上有效期間百洋醫藥完成雙方約定的設定指標,且甲乙雙方對之後的合作政策達成一致意見,則本協議自動延期至2029年12月31日。

次公司與上海誼眾合作推廣的注射用紫杉醇聚合物膠束為廣譜抗癌化療藥紫杉醇的創新劑型,屬於國家重大新藥創制項目。公司取得該產品的市場推廣權,有利於豐富公司創新成果孵化、醫藥品牌運營和商業化推廣的資源和管理經驗;同時此次簽約拓展了公司在抗癌抗腫瘤領域產品的商業化合作,豐富了公司運營的品牌矩陣,有助於提高公司品牌影響力,提升公司的市場競爭力,後續如在合作區域商業化成功,將對公司業績產生積極影響,提升公司持續盈利能力。

該協議的簽訂預計對公司本年度及未來年度經營業績產生積極影響,有利於提升公司收入規模和持續盈利能力。該協議的簽訂和履行對公司業務獨立性不構成重大影響,公司主營業務不會因本協議的履行而對協議對方形成依賴。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account